Previous 10 | Next 10 |
Gainers: Entera Bio ENTX +297%, PDS Biotechnology PDSB +56%, Longeveron LGVN +31%, Vir Biotechnology VIR +30%, OrganiGram OGI +29%.Losers: Enveric Biosciences (ENVB) -24%, Invacare (IVC) -20%, INVO Bioscience (INVO) -20%,...
Alto Ingredients (ALTO) -16% on Q4 earnings releaseMediciNova (MNOV) -16%.Savara (SVRA) -13% on proposed public offering of stockJust Energy Group (JE) -13% after announces Toronto Stock Exchange and New York Stock Exchange have commenced delisting proceedings.Enveric...
Shares of MediciNova (NASDAQ: MNOV) soared on Wednesday after the biopharmaceutical company announced a collaboration with the U.S. Department of Health and Human Services (HHS). By the close of trading, MediciNova's stock price was up 54% after having been up by as much as 90% ...
These Health Care Stocks Are Trending In The Market This Week Health care was one of the most important sectors in the last year. When the pandemic struck, the health care industry was pushed to the limit. With over 118 million people infected and over 2.6 million deaths from the co...
Gainers: Enveric Biosciences (ENVB) +102%.Cemtrex (CETX) +60%.Koss (KOSS) +54%.MediciNova (MNOV) +41%.Express (EXPR) +28%.Talend (TLND) +28%.Evofem Biosciences (EVFM) +27%.SIFCO Industries (SIF) +21%.United Natural Foods (UNFI) +20%.Pyxis Tankers (PXS) +16%.Losers: Just Energy ...
Gainers: Enveric Biosciences (ENVB) +86%, MediciNova (MNOV) +53%, Artelo Biosciences (ARTL) +23%, Inari Medical (NARI) +15%.Losers: INVO Bioscience (INVO) -34%, Second Sight Medical Products (EYES) -26%, Sintx Technologies (SINT) -23%, Au...
MediciNova (MNOV) +87% on BARDA partnership for Ibudilast development.Cemtrex (CETX) +85%.Koss Corporation (KOSS) +50%.Obalon Therapeutics (OBLN) +34%.Enveric Biosciences (ENVB) +39% on agreement to acquire exclusive license for novel molecules from Diverse Biotech.MoneyGram Interna...
MediciNova (MNOV) has climbed ~60.5% in the post-market after the company announced a development agreement with the Biomedical Advanced Research and Development Authority (BARDA) for its small molecule candidate MN-166 (ibudilast).Under the partnership with BARDA, the com...
LA JOLLA, Calif., March 09, 2021 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced it has partnered with the Biomedical Advanced Research a...
In order to maintain adequate resources for its other development programs, MediciNova (MNOV) has decided to discontinue development of a SARS-CoV-2 vaccine for COVID-19.The company has conduced a review of its numerous development programs to determine the best allocation of resources going ...
News, Short Squeeze, Breakout and More Instantly...
Company to rededicate efforts toward updating stakeholders on corporate vision, strategy, and ongoing activities LA JOLLA, Calif., June 20, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market o...
LA JOLLA, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that it has received a Notice of Allowance from the U.S....
LA JOLLA, Calif., June 03, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that MediciNova’s collaborator, Gilbert Youssef, M.D....